Heron Therapeutics, Inc. (HRTX) vs LeonaBio, Inc. (LONA)

Heron Therapeutics, Inc. and LeonaBio, Inc. are both Biotechnology companies. Heron Therapeutics, Inc. and LeonaBio, Inc. are of similar size ($57.0M and $54.3M). LeonaBio, Inc. has the higher net margin (0.00% vs −22.5%) and the higher return on invested capital (0.00% vs −6.35%). Across the 14 metrics below, LeonaBio, Inc. leads on 8 and Heron Therapeutics, Inc. on 6.

Valuation

Metric HRTX LONA Biotechnology median
P/E n/m n/m 7.88
P/S 0.38 n/m 11.47
P/B 9.75 2.30 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 1.04 n/m 10.73
Earnings yield (63.33%) (708.88%) (28.84%)
Free cash flow yield (21.17%) (80.10%) (23.03%)

Profitability

Metric HRTX LONA Biotechnology median
Gross margin 70.07% 0.00% 65.16%
Operating margin (7.19%) 0.00% 0.00%
Net margin (22.52%) 0.00% 0.00%
Free cash flow margin (8.00%) 0.00% 0.00%
Return on equity 318.21% (431.39%) (57.72%)
Return on assets (14.06%) (306.05%) (49.22%)
Return on invested capital (6.35%) 0.00% 0.00%

Growth

Metric HRTX LONA Biotechnology median
Revenue growth (TTM) 0.99% — 5.64%
EPS growth (last fiscal year) (33.33%) 1.98% —
Revenue growth, 5-year CAGR 11.81% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HRTX LONA Biotechnology median
Debt to equity 20.65 0.00 0.00
Current ratio 2.49 7.01 4.73
Net debt to EBITDA (643.88) 0.87 0.96

Dividend

Metric HRTX LONA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric HRTX LONA Biotechnology median
Market cap 56.96m 54.26m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack